Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Chlorpromazine, developed in the early 1950s, is a phenothiazine antipsychotic primarily used to treat schizophrenia and other psychiatric disorders. It functions by blocking dopamine receptors in the brain, which helps alleviate symptoms of psychosis. Chlorpromazine is located on chromosome 22q13.1, and its structure includes a tricyclic phenothiazine core with a side chain that influences its pharmacological activity. The drug has been repurposed for various treatments, including anti-leukaemic therapy and triple-negative breast cancer, due to its ability to cross the blood-brain barrier and interact with central nervous system pathways. Chlorpromazine's versatility extends to its use in novel drug delivery systems, such as the drug-in-cyclodextrin-in-liposome platform, enhancing its therapeutic potential.
仅用于科研。不用于诊断过程。未经明确授权不得转售。